Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants
Clinical trial NCT05546957 · COMPLETED
Trial details
- NCT number
- NCT05546957
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-05
- Primary completion
- 2023-04-06
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.